ITIF’s new paper outlines the reasons why the intellectual property provisions of trade deals such as TPP are not only of particular importance to the life sciences industry, but to many healthcare advocacy NGOs seeking the innovation that biologics research is producing to create new life-saving medicines, writes GHY.
